When mass spectrometry redefines the pharma industry

In this new episode of omg OMx, Kate Stumpo speaks to Bruker’s Mike Greig about the incredible
potential of mass spectrometry in pharma.

Researchers Hit the Road to Learn Why CVD and COPD Are Rampant in the Rural South

Darrell Dixon’s father was just 25 when he had a major heart attack in the rural Mississippi Delta. By his early 40s, a series of

August 20, 2024

MDMA’s Cardiac Safety Concerns; Entresto Generics; Heart Disease ‘Older Than Moses’

FDA reviewers questioned the cardiac safety of midomafetamine (MDMA), among other concerns raised ahead of an advisory committee meeting on a potential drug indication for

June 5, 2024

In ‘major milestone,’ FDA approves first cell therapy for solid tumors

Nearly four decades after its first conception, the first TIL therapy, an immunotherapy that harvests cancer-fighting immune cells from the patient’s own body, received accelerated

February 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.